Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial

被引：0

作者：

Orly Vardeny

James C. Fang

Akshay S. Desai

Pardeep S. Jhund

Brian Claggett

Muthiah Vaduganathan

Rudolf A. de Boer

Adrian F. Hernandez

Carolyn S. P. Lam

Silvio E. Inzucchi

Felipe A. Martinez

Mikhail N. Kosiborod

David DeMets

Eileen O’Meara

Shelley Zieroth

Josep Comin-Colet

Jaroslaw Drozdz

Chern-En Chiang

Masafumi Kitakaze

Magnus Petersson

Daniel Lindholm

Anna Maria Langkilde

John J. V. McMurray

Scott D. Solomon

机构：

[1] University of Minnesota,Minneapolis VA Center for Care Delivery and Outcomes Research

[2] University of Utah Medical Center,BHF Glasgow Cardiovascular Research Center, School of Cardiovascular and Metabolic Health

[3] Cardiovascular Division, Department of Cardiology, Thoraxcenter

[4] Brigham and Women’s Hospital,Cardiology Department

[5] Harvard Medical School,Department Cardiology

[6] University of Glasgow,General Clinical Research Center and Division of Cardiology

[7] Erasmus Medical Center,undefined

[8] Duke University Medical Center,undefined

[9] National Heart Centre Singapore and Duke–National University of Singapore,undefined

[10] Yale School of Medicine,undefined

[11] Universidad Nacional de Córdoba,undefined

[12] Saint Luke’s Mid America Heart Institute and University of Missouri-Kansas City,undefined

[13] University of Wisconsin,undefined

[14] Montreal Heart Institute and Université de Montréal,undefined

[15] St. Boniface Hospital & University of Manitoba,undefined

[16] Bellvitge University Hospital,undefined

[17] Bio-Heart Bellvitge Institute for Biomedical Research,undefined

[18] University of Barcelona,undefined

[19] Hospitalet de Llobregat,undefined

[20] Medical University Lodz,undefined

[21] Taipei Veterans General Hospital and National Yang Ming Chiao Tung University,undefined

[22] Kinshukai Hanwa Daini Senboku Hospital,undefined

[23] Late-Stage Development,undefined

[24] Cardiovascular,undefined

[25] Renal,undefined

[26] and Metabolism,undefined

[27] BioPharmaceuticals R&D,undefined

[28] AstraZeneca,undefined

来源：

Nature Medicine | 2023年 / 29卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：3269 / 3269

共 50 条

[41] Letter by Wong and Demers Regarding Article, "Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial" [J].

Wong, Eric K. C. ;

Demers, Catherine .

CIRCULATION, 2023, 147 (14) :1118-1118

[42] Dapagliflozin reduces loop diuretic requirement over time in patients with heart failure with mildly reduced or preserved ejection fraction in the DELIVER Trial [J].

Chatur, Safia ;

Vaduganathan, M. ;

Claggett, B. ;

Vardeny, O. ;

Desai, A. S. ;

Jhund, P. S. ;

De Boer, R. A. ;

Lam, C. S. P. ;

Kosiborod, M. N. ;

Shah, S. J. ;

Martinez, F. ;

Inzucchi, S. E. ;

Hernandez, A. F. ;

Mc Murray, J. J. V. ;

Solomon, S. D. .

EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 :39-40

[43] Effect of dapagliflozin in patients in Asia with heart failure with mildly reduced or preserved ejection fraction: insights from DELIVER [J].

Wang, X. ;

Lam, C. S. P. ;

Claggett, B. ;

Miao, M. ;

Shah, S. J. ;

Jhund, P. S. ;

Desai, A. S. ;

Chiang, C. ;

Pham, V. N. ;

Han, Y. ;

Kitakaze, M. ;

Langkilde, A. M. ;

Mcmurray, J. J. V. ;

Solomon, S. D. ;

Vaduganathan, M. .

EUROPEAN HEART JOURNAL, 2023, 44

[44] Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction [J].

Solomon, S. D. ;

McMurray, J. J., V ;

Claggett, B. ;

de Boer, R. A. ;

DeMets, D. ;

Hernandez, A. F. ;

Inzucchi, S. E. ;

Kosiborod, M. N. ;

Lam, C. S. P. ;

Martinez, F. ;

Shah, S. J. ;

Desai, A. S. ;

Jhund, P. S. ;

Belohlavek, J. ;

Chiang, C-E ;

Borleffs, C. J. W. ;

Comin-Colet, J. ;

Dobreanu, D. ;

Drozdz, J. ;

Fang, J. C. ;

Alcocer-Gamba, M. A. ;

Al Habeeb, W. ;

Han, Y. ;

Cabrera Honorio, J. W. ;

Janssens, S. P. ;

Katova, T. ;

Kitakaze, M. ;

Merkely, B. ;

O'Meara, E. ;

Saraiva, J. F. K. ;

Tereshchenko, S. N. ;

Thierer, J. ;

Vaduganathan, M. ;

Vardeny, O. ;

Verma, S. ;

Pham, V. N. ;

Wilderang, U. ;

Zaozerska, N. ;

Bachus, E. ;

Lindholm, D. ;

Petersson, M. ;

Langkilde, A. M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2022, :1089-1098

[45] Dapagliflozin: A Review in Symptomatic Heart Failure with Reduced Ejection Fraction [J].

Blair, Hannah A. .

AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2021, 21 (06) :701-710

[46] Dapagliflozin in Heart Failure with Preserved Ejection Fraction-Reply [J].

Kjaergaard, Jesper ;

Moller, Jacob E. ;

Hassager, Christian .

NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (03) :285-286

[47] Efficacy of Dapagliflozin in Heart Failure with Preserved Ejection Fraction in the Elderly [J].

Bu, X. P. ;

Li, C. X. ;

Li, L. ;

Liu, Y. R. .

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2023, 71 :S24-S24

[48] Dapagliflozin: A Review in Symptomatic Heart Failure with Reduced Ejection Fraction [J].

Hannah A. Blair .

American Journal of Cardiovascular Drugs, 2021, 21 :701-710

[49] Anaemia in patients with heart failure and mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS-HF trial [J].

Chimura, Misato ;

Yang, Mingming ;

Henderson, Alasdair D. ;

Jhund, Pardeep S. ;

Docherty, Kieran F. ;

Claggett, Brian L. ;

Desai, Akshay S. ;

Filippatos, Gerasimos ;

Gajos, Grzegorz ;

Mueller, Katharina ;

Glasauer, Andrea ;

Rohwedder, Katja ;

Viswanathan, Prabhakar ;

Lam, Carolyn S. P. ;

Sato, Naoki ;

Senni, Michele ;

Voors, Adriaan A. ;

Zannad, Faiez ;

Yilmaz, Mehmet B. ;

Pitt, Bertram ;

Vaduganathan, Muthiah ;

Solomon, Scott D. ;

McMurray, John J. V. .

EUROPEAN JOURNAL OF HEART FAILURE, 2025,

[50] Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction REPLY [J].

McMurray, John J. V. ;

Docherty, Kieran F. ;

Jhund, Pardeep S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (10) :973-973

← 1 2 3 4 5 →